Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_assertion type Assertion NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_head.
- NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_assertion description "[Our data strongly suggest that humanized anti-CD26 mAb treatment may have potential clinical use as a novel cancer therapeutic agent in CD26-positive malignant mesothelioma.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_provenance.
- NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_assertion evidence source_evidence_literature NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_provenance.
- NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_assertion SIO_000772 17634548 NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_provenance.
- NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_assertion wasDerivedFrom befree-20150227 NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_provenance.
- NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_assertion wasGeneratedBy ECO_0000203 NP358710.RAyVaLXr-kZsUcE0v5RWvpzS9p0wdX6rr2bVLIb3Qauww130_provenance.